Discovering targeted inhibitors for Escherichia coli efflux pump fusion proteins using computational and structure‐guided approaches

SS Chauhan, A Gupta, A Srivastava… - Journal of …, 2024 - Wiley Online Library
Multidrug resistance pathogens causing infections and illness remain largely untreated
clinically. Efflux pumps are one of the primary processes through which bacteria develop …

Theoretical analysis of bacterial efflux pumps inhibitors: Strategies in-search of competent molecules and develop next

A Ghosh, G Roymahapatra, D Paul… - Computational Biology and …, 2020 - Elsevier
Multi-drug resistance (MDR) bacteria pose a significant threat to our ability to effectively treat
infections due to the development of several antibiotic resistant mechanisms. A major …

Virtual screening and biological activity evaluation of novel efflux pump inhibitors targeting AdeB

Y Tuo, Y Tang, R Yang, XM Zhao, M Luo, X Zhou… - International Journal of …, 2023 - Elsevier
The AdeABC efflux pump is an important mechanism causing multidrug resistance in
Acinetobacter baumannii, and its main component AdeB can recognize carbapenems …

[HTML][HTML] Bac-EPIC: A web interface for developing novel efflux pump inhibitor compounds targeting Escherichia coli

SS Chauhan, P Pandey, S Manickam… - Medicine in Drug …, 2023 - Elsevier
Multidrug resistance (MDR) poses a severe threat to human health. The existence of efflux
pumps primarily contributes to resistance in Gram-negative bacterial infections. Efflux pump …

Identification of efflux pump inhibitors for Pseudomonas aeruginosa MexAB-OprM via ligand-based pharmacophores, 2D-QSAR, molecular docking, and molecular …

TV Phan, VTV Nguyen, MT Le, BGD Nguyen, TT Vu… - Molecular Diversity, 2023 - Springer
Efflux pumps have been reported as one of the significant mechanisms by which bacteria
evade the effects of multiple antibiotics. The tripartite efflux pump MexAB-OprM in …

Analysis of orthogonal efflux and permeation properties of compounds leads to the discovery of new efflux pump inhibitors

M Moniruzzaman, CJ Cooper, MR Uddin… - ACS infectious …, 2022 - ACS Publications
Optimization of compound permeation into Gram-negative bacteria is one of the most
challenging tasks in the development of antibacterial agents. Two permeability barriers─ …

Targeting outer membrane protein component AdeC for the discovery of efflux pump inhibitor against AdeABC efflux pump of multidrug resistant Acinetobacter …

P Verma, V Tiwari - Cell Biochemistry and Biophysics, 2018 - Springer
The structure and functioning of multidrug efflux systems provide us with a better
understanding of the transport of various antibiotics, thus giving a path for the discovery of …

Identification of Natural Compound Inhibitors for Multidrug Efflux Pumps of Escherichia coli and Pseudomonas aeruginosa Using In Silico High-Throughput Virtual Screening …

V Aparna, K Dineshkumar, N Mohanalakshmi… - PloS one, 2014 - journals.plos.org
Pseudomonas aeruginosa and Escherichia coli are resistant to wide range of antibiotics
rendering the treatment of infections very difficult. A main mechanism attributed to the …

Discovery of multidrug efflux pump inhibitors with a novel chemical scaffold

AT Green, M Moniruzzaman, CJ Cooper… - … et Biophysica Acta (BBA …, 2020 - Elsevier
Multidrug efflux is a major contributor to antibiotic resistance in Gram-negative bacterial
pathogens. Inhibition of multidrug efflux pumps is a promising approach for reviving the …

In silico screening for antibiotic escort molecules to overcome efflux

SS Rahman, I Simovic, S Gibbons, M Zloh - Journal of molecular modeling, 2011 - Springer
Resistance to antibiotics is a growing problem worldwide and occurs in part due to the
overexpression of efflux pumps responsible for the removal of antibiotics from bacterial cells …